ALZpath Inc.

ALZpath Inc. is dedicated to transforming the Alzheimer’s disease ecosystem through earlier diagnosis and personalized treatment to improve outcomes for individuals affected by this condition. Located at 2292 Faraday Ave, Carlsbad, California 92008, US (Primary address), ALZpath Inc. is focused on accelerating novel diagnostic solutions.

The company offers a simple, accessible, timely, and cost-effective approach to diagnosis with a novel blood-based biomarker assay for phosphorylated tau 217 (ptau217). This less-invasive testing method provides a transformative AD diagnostic biomarker, closely reflecting amyloid and tau pathology, which are hallmarks of Alzheimer’s disease. ALZpath Inc. continues to drive advancements in biotechnology research.

ALZpath Inc. is committed to medical research and healthcare, aiming to make a significant impact on the lives of those affected by Alzheimer’s. The company’s work promises to enhance the future of Alzheimer’s diagnostics and interventions. We invite the manager of ALZpath Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight these innovative solutions.